News
-
NanoViricides Has Received Regulatory Approval for a Phase II Clinical Trial of NV-387 Oral Gummies as a Treatment for Ebola in DR Congo To Fight the Current Largest Ever and Expanding Ebola Outbreak
-
Sterling Expands High-Grade Copper Mineralization East at MEPS Intersecting 203 Metres at 0.51% CuEq: Includes 16.25 Metres at 2.31% CuEq and 9.50 Metres at 2.34% CuEq within 445 Metres at 0.40% CuEq
-
Alaska Energy Metals Announces Drilling Program for the Mcbride Prospect, Angliers-Belleterre Project, Quebec, Canada
-
Azarga Metals Mobilizes Drill Rig and Ancillary Equipment to Marg Project, Yukon
-
NioCorp to Host Webcast on Aug. 11 to Discuss Elk Creek Feasibility Study Results
-
GUILLEMOT CORPORATION | Information regarding the total number of voting rights and shares 31/07/2026
-
GUILLEMOT CORPORATION| Weekly report share buyback from August 3 to August 7 2026
-
Number of shares and voting rights - July 2026 (In French only)
-
BIOPHYTIS ANNOUNCES APPROVAL OF THE OBA CLINICAL TRIAL IN BRAZIL AND SHARES ITS OUTLOOK FOR BIO101 IN OBESITY
-
Covivio - Information on Treasury shares transactions between August 3rd, 2026, and August 7th, 2026